首页> 外文期刊>FEBS Letters >Mutations in TOP2B cause autosomal‐dominant hereditary hearing loss via inhibition of the PI3K‐Akt signalling pathway
【24h】

Mutations in TOP2B cause autosomal‐dominant hereditary hearing loss via inhibition of the PI3K‐Akt signalling pathway

机译:TOP2B中的突变导致通过抑制PI3K-AKT信号通路的血栓组显性遗传性损失

获取原文
           

摘要

Hereditary hearing impairment is a clinically and genetically heterogeneous disease. Whole‐exome sequencing was performed on seven affected and six unaffected members in a large Chinese family with autosomal‐dominant nonsyndromic hearing loss. The pathogenic variant of the gene encoding human topoisomerase IIβ TOP2B (c.G4837C:p.D1613H) was cosegregated with hearing loss in this pedigree and another two variants of TOP2B were detected in 66 sporadic patients with hearing loss. top2b knockdown led to significant defects in zebrafish inner ears and caused downregulation of akt which resulted in inactivation of PI3K‐Akt signalling. As a result, supporting cell and hair cell numbers were reduced through inhibition of the PI3K‐Akt pathway. Therefore, we hypothesized that mutations in TOP2B can cause autosomal‐dominant nonsyndromic hearing impairment through inhibition of the PI3K‐Akt signalling pathway.
机译:遗传性听力障碍是临床和基因上的异质疾病。在一个大型中国家庭中,在一个受到常染色体占优势不健康的听力损失的大型中国家庭中进行全面测序。编码人拓扑异构酶IIβTOP2B(C.G4837C:P.D1613h)的致病性变体被CoSegregated与该血统中的听力损失,在66例听力损失中检测到另外两种TOP2B的变体。 TOP2B敲低导致斑马鱼内耳的显着缺陷,并导致AKT的下调,导致PI3K-AKT信号传导。结果,通过抑制PI3K-AKT途径来降低支持细胞和毛细胞数。因此,我们假设TOP2B中的突变通过抑制PI3K-AKT信号通路,可以引起常染色体显性的非合成型听力损伤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号